BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Clinical Research

Aichi Cancer Center & NEC Advance Lung Cancer Antigen Identification

Aichi Cancer Center and NEC developed a method for efficiently identifying lung cancer antigens (oncology marks) and antigen-specific T cells by comb...

August 10, 2023 | News

Agilent Inaugurates First Integrated Biology Center at Monash University in Malaysia

Agilent Technologies Inc. (NYSE: A) announced the opening of a new full-scale Integrated Biology Center located at Monash University in Ma...

August 08, 2023 | News

DualityBio, BioNTech Expand Partnership for Solid Tumor Antibody-Drug Conjugate

The agreement further builds upon the strategic collaboration the companies announced in April 2023. Under the terms of the agreements, DualityBio will re...

August 08, 2023 | News

Pfizer Malaysia Teams Up with Sunway Medical Centre and Pharmacy to Promote Early Atrial Fibrillation Detection

In the initial phase of the AF360 campaign, Pfizer, via its distributor, has provided registered medical portable ECG screening devices to Sunway Multicare...

August 08, 2023 | News

Certara Teams Up with Korea Institute of Toxicology for FDA-Ready SEND Dataset

Certara, Inc. (Nasdaq: CERT), a global leader in Biosimulation, today announced that a Korea Institute of Toxicology (KIT) have decided to implement Certar...

August 04, 2023 | News

MANA Develops Novel "Drycell" Microdroplets to Make Handling Single Cell Easier

To analyze individual cells, the desired number of cells must be isolated spatially. This often requires extensive training and use of expensive laboratory...

August 04, 2023 | News

Peter Mac launches BindiMaps to help patients and visitors with vision impairments

The newly-installed service functions like Google Maps, but has been specifically developed to work indoors with a 10 to 20 times higher accuracy than GPS ...

August 03, 2023 | News

NMPA and FDA Approve First-in-Human Trial for LBL-034 in Multiple Myeloma

This is a first-in-human, single-arm, multicenter, open-label, dose-escalation and expansion clinical study, and plans to enroll patients with relapsed/ref...

August 01, 2023 | News

Daewoong Pharmaceutical Seeks Approval for Fexuprazan in China's Anti-Ulcer Drug Market

Daewoong Pharmaceutical's domestically produced drug no. 34 Fexuprazan, a newly developed one for the treatment of gastroesophageal reflux disease (GERD), ...

July 31, 2023 | News

Transcenta's Anti-sclerostin Antibody TST002 Approved for Phase II Trial in China for Reduced Bone Density Patients

This study aims to evaluate the safety, tolerability, and pharmacokinetics of TST002(Blosozumab) after single and multiple intravenous administrations in p...

July 31, 2023 | News

MSD and Moderna Launch Phase 3 Study for Melanoma Treatment

“As we continue our efforts to advance novel treatment options for patients with high-risk Stage IIB-IV melanoma, the initiation of the V940-001 Phas...

July 28, 2023 | News

AI Medical Service Inc. Signs Joint Research Agreement with Stanford Medicine

AI Medical Service Inc. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, has signed a joint research...

July 28, 2023 | News

GC Genome Enables Prognosis Prediction and Targeted Treatment in Breast Cancer

''We can gain vital insights into patient prognosis and make informed decisions regarding the most effective treatment strategies through ctDNA CNA...

July 27, 2023 | News

Hummingbird Bioscience Advances HMBD-001 Phase IB Trials in Australia, Partners with Omico for Faster Clinical Development

Hummingbird Bioscience has initiated two clinical trials in Australia evaluating HMBD-001 in patients with squamous non-small cell lung ca...

July 27, 2023 | News

Stay Connected